Proposal for a new model of breast cancer metastatic development

被引:110
作者
Demicheli, R
Retsky, MW
Swartzendruber, DE
Bonadonna, G
机构
[1] Ist Nazl Tumori, Div Oncol Med A, I-20133 Milan, Italy
[2] Univ Colorado, Colorado Springs, CO 80907 USA
关键词
Gompertzian kinetics; stochastic model; surgery signals; tumor dormancy; tumor growth;
D O I
10.1023/A:1008263116022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The commonly accepted theory of breast cancer metastatic development assumes continuous tumor growth from tumor seeding until documentation of clinical recurrence. In particular, Gompertzian growth kinetics is currently the theoretical cornerstone of the natural history of breast cancer, and has been widely utilized for planning treatments. Materials and methods: To verify agreement between findings and the implications of the continuous growth model, several published papers about the natural history of breast cancer after removal of the primary tumor were reviewed. Also, findings from animal models concerning metastasis biology were considered. Results: The continuous growth model failed in important ways upon this critical reappraisal. As an alternative, the tumor dormancy hypothesis was considered to provide a more reasonable description of tumor recurrence. Moreover, primary tumor removal was revealed as a potentially perturbing factor for metastasis development. Conclusions: A new general outline of metastatic development of breast cancer incorporating tumor dormancy in specific micrometastatic phases, stochastic transitions between them, and start signals from surgery for micrometastatic growth was designed. The proposed model suggests new views concerning scheduling of current chemotherapy, new treatment approaches aimed at keeping micrometastases in a dormant state for the patient's entire life, and the careful reappraisal of the timing of surgery within the multimodal treatment of operable breast cancer.
引用
收藏
页码:1075 / 1080
页数:6
相关论文
共 49 条
[1]   PROGNOSTIC FACTORS IN RECURRENT BREAST-CANCER - RELATIONSHIPS TO SITE OF RECURRENCE, DISEASE-FREE INTERVAL, FEMALE SEX STEROID-RECEPTORS, PLOIDY AND HISTOLOGICAL MALIGNANCY GRADING [J].
BLANCO, G ;
HOLLI, K ;
HEIKKINEN, M ;
KALLIONIEMI, OP ;
TASKINEN, P .
BRITISH JOURNAL OF CANCER, 1990, 62 (01) :142-146
[2]  
Braunschweiger PG, 1982, BREAST CANC RES TREA, V2, P323, DOI DOI 10.1007/BF01805873]
[3]  
CastiglioneGertsch M, 1996, J CLIN ONCOL, V14, P1885
[4]   SURVIVAL FROM 1ST RECURRENCE - RELATIVE IMPORTANCE OF PROGNOSTIC FACTORS IN 1,015 BREAST-CANCER PATIENTS [J].
CLARK, GM ;
SLEDGE, GW ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) :55-61
[5]  
CROWE JP, 1991, ARCH SURG-CHICAGO, V126, P429
[6]  
CROWLEY NJ, 1992, ARCH SURG-CHICAGO, V127, P1303
[7]   Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy [J].
Demicheli, R ;
Abbattista, A ;
Miceli, R ;
Valagussa, P ;
Bonadonna, G .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 41 (02) :177-185
[8]  
DEMICHELI R, 1994, J NATL CANCER I, V86, P45
[9]  
DEMICHELI R, 1995, ANTICANCER DRUGS S2, V6, P77
[10]  
*EARL BREAST CANC, 1991, LANCET, V339, P1